The Friends of the Co-Chairs Group on Liability and Redress in the Context of the Cartagena Protocol on Biosafety held its second meeting in Kuala Lumpur, Malaysia on 8-12 February 2010. This is a TWN report of the meeting. […]
|
||||||
|
The Friends of the Co-Chairs Group on Liability and Redress in the Context of the Cartagena Protocol on Biosafety held its second meeting in Kuala Lumpur, Malaysia on 8-12 February 2010. This is a TWN report of the meeting. […] Parties to the UN Cartagena Protocol on Biosafety, in February 2009, have agreed that a legally-binding Supplementary Protocol will be developed on liability and redress for damage from GMOs. […] Four years of negotiations on an international liability and redress regime for GMOs under the Biosafety Protocol have failed to conclude as planned. […] Paper prepared for the 4th meeting of the Conference of Parties of the Biosafety Protocol, 12-14 May 2008 […] Negotiations under the UN Cartagena Protocol on Biosafety to establish an international regime for liability and redress for damage caused by genetically modified organisms (GMOs) failed to conclude as mandated. […] A meeting of a working group under the UN Convention on Biological Diversity made progress to develop an international regime for the fair and equitable sharing of benefits arising out of the utilization of genetic resources. […] This short briefing prepared for the WHO Executive Board meeting provides an update on developments on the issue of destruction of smallpox virus stocks since the 59th World Health Assembly in May 2006. […] This note explains what the WTO Dispute Panel on the EC biotechnology case decided, what might be appealed, and what might be important to developing countries wanting to regulate GM imports and other products. […] An analysis by Greenpeace of the WTO Interim Report of the European Communities – Measures affecting the Approval and Marketing of Biotech Products case. […] The present note provides an overview of the main findings and reasoning in the WTO Panel’s Interim Report on the case “European Communities – Measures Affecting the Approval and Marketing of Biotech Products” […] |
||||||
|
All our content may be republished or reused for free, except where otherwise noted. This site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Powered by WordPress & Atahualpa |
||||||